clebopride
This page covers all clebopride drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(4) dopamine receptor, Acetylcholinesterase, D(2) dopamine receptor.
Targets
D(4) dopamine receptor, Acetylcholinesterase, D(2) dopamine receptor
Phase 2 pipeline (1)
- CLEBOPRIDE · Gastroenterology
CLEBOPRIDE works by binding to the D(4) dopamine receptor, which helps to regulate gastrointestinal motility.
Patent intelligence
- clebopride patent landscape — aggregated cliff calendar, attackable patents, originator estates